Preview Newsletter
Talc 7/14
-
Welcome to MND on Talcum Powder and Ovarian Cancer
Jul 13, 2016 | Mesh Medical Device News Desk
Welcome to MND. For five years Mesh News Desk has covered primarily the injuries coming from mesh created to be permanently placed in the pelvis in women. There are now more lawsuits consolidated in one court than for any other dangerous consumer product. -
Missouri Federal Court Remands Talcum Powder Suit, Says Claims of 80 Plaintiffs Not Misjoined
Jul 13, 2016 | Harris Martin Publishing
A Missouri federal court has remanded a talcum powder exposure suit, rejecting Johnson & Johnson’s position that the claims of 80 plaintiffs were misjoined and finding that the underlying claims were “sufficiently related to support joinder in this case.” -
February 2017 Date set for Talcum Powder Lawsuit in Missouri
Jul 13, 2016 | News Inferno
By Mara Lepmanis
In a consolidated litigation presently underway in Missouri, hundreds of talcum powder ovarian cancer lawsuits continue to move forward. -
$55 Million Verdict Second Against Johnson & Johnson in Talc Ovarian Cancer Lawsuit
Jul 13, 2016 | The Legal Examiner
By James Humann
In landmark verdicts this year two juries have found Johnson & Johnson liable for knowingly failing to warn customers that the company’s talcum powder products (including Shower-to-Shower and Johnson’s Baby Powder) have been linked to ovarian cancer in women. -
Imerys Talc Moves to Dismiss Talcum Powder Suit on Jurisdiction, Venue and Failure to State a Claim Grounds
Jul 13, 2016 | Harris Martin Publishing
Imerys Talc America Inc. has filed a motion to dismiss a New Mexico talcum powder lawsuit on a number of grounds, including that the court does not have personal jurisdiction over the matter and that the plaintiffs’ civil conspiracy and fraud claims have not been pled with sufficient particularity.
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
US Coverage
-
Welcome to MND on Talcum Powder and Ovarian Cancer
Jul 13, 2016 | Mesh Medical Device News Desk
Welcome to MND. For five years Mesh News Desk has covered primarily the injuries coming from mesh created to be permanently placed in the pelvis in women. There are now more lawsuits consolidated in one court than for any other dangerous consumer product.
The site was created to follow the issue and inform. It is not medical or legal advice.
There seems to be a disproportionate number of medical devices and consumer products sold to women. Major pharmaceutical companies know women are the primary consumers for most households. Drugs are often seen with females in commercials. Just consider depression medication – those commercials almost always feature a woman.
Big Pharma knows that some women are willing recipients of marketing. Other women are developing a critical eye toward medical marketing. That is probably a good thing.
The same thing goes for consumer products.
Talcum powder has been used for decades by women to “stay fresh” and its often used around the genital area. Some women put it in their underwear and do so every time they bathe. Even thought there were warnings 20 years ago about talc’s link to cancer (Check out the Cancer Prevention Coalition) , it did not make the mainstream media. Now, we are hearing the news. How many women have been affected because they didn’t know? For some, it is too late. That’s what the trials are showing us.
While the link is not conclusive, there are too many correlations to ignore the facts. With more than 2,000 cases of ovarian cancer diagnosed in the US each year, talc manufacturer understood the cancer risks associated with its talc products but failed to warn consumers. How many women might not have cancer if the Johnson’ Baby Powder or Shower to Shower contained a warning? The stories that follow are intended to inform the reader about the risks, what is know and what is speculative so you can be an informed consumer.
Dr. Greg Vigna, MD and JD would like to help you with consulting on your condition if you have been diagnosed with ovarian cancer.
Dr. Greg Vigna is a practicing rehabilitation physician, a certified Life Care Planner, and an attorney. He has cared for patients with serious, life threatening injuries for over 20 years. His vocation and life mission are to help patients regain the greatest quality of life possible.
Dr. Vigna became an attorney because of his frustration with changes in the health care industry that prevented patients from receiving the highest standard of care. He believes that both government and private insurance companies ration care to the detriment of patients who are disabled by their injuries.
In addition, pharmaceutical and device companies have profited from pushing products to market, and not completing adequate safety research despite warnings that their products were causing serious injury. Dr. Vigna and his staff have witnessed the life-long suffering these patients experience. Many patients lose their ability to work, pay bills, and receive adequate medical care.
As an advocate Dr. Vigna is uniquely prepared to understand the nature of your injuries, and advocate for you either via settlement negotiations or in a court of law. He is experienced in national level litigation and together with partner attorneys takes on multi-national businesses such as Johnson & Johnson, BP, and others.
Much of our writing is done by Eva Hvingelby NP, PhD is a Nurse Practitioner, writer, educator and researcher. She has been working in health care for over 25 years with a focus on traumatic injury and terminal illness.
Eva completed a Master of Science and Nurse Practitioner degree at the University of California, Los Angeles (UCLA). She then completed a Master of Arts in Organizational Systems, and a PhD in Human Development at the Fielding Institute; she pursued the PhD to better understand why individuals make both healthy and unhealthy choices throughout their lifetimes. Eva is a strong patient advocate. She believes every patient deserves to understand their rights, and all medical options available to help them gain the best quality of life possible.
MND was founded by Jane Akre five years ago. She learned about the talcum powder link to cancer 20 years ago when she was warned by Dr. Samuel Epstein professor emeritus of Environmental and Occupational Medicine at the University of Illinois at Chicago School of Public Health, and Chairman of the Cancer Prevention Coalition; and former President of the Rachel Carson Trust. His awards include the 1998 Right Livelihood Award and the 2005 Albert Schweitzer Golden Grand Medal for International Contributions to Cancer Prevention. Read Epstein writing on more preventable environmental cancers at Physicians for Social Responsibility. MND will continue to follow the issue and is in the process of creating Women’s Health News Desk to include all products that may present a danger to women.
http://www.meshmedicaldevicenewsdesk.com/welcome-mnd-talcum-powder-ovarian-cancer/
-
Missouri Federal Court Remands Talcum Powder Suit, Says Claims of 80 Plaintiffs Not Misjoined
Jul 13, 2016 | Harris Martin Publishing
A Missouri federal court has remanded a talcum powder exposure suit, rejecting Johnson & Johnson’s position that the claims of 80 plaintiffs were misjoined and finding that the underlying claims were “sufficiently related to support joinder in this case.”
In the July 11 ruling, the U.S. District Court for the Eastern District of Missouri said that the defendants had failed to demonstrate diversity of citizenship and, as a result, the court lacked subject matter jurisdiction over the case.
The underlying suit was filed by 80 plaintiffs, all of whom alleged that they developed ovarian cancer as a ...
Subscription required, for full text: http://harrismartin.com/article/21076/missouri-federal-court-remands-talcum-powder-suit-says-claims-of-80-plaintiffs-not-misjoined/
-
February 2017 Date set for Talcum Powder Lawsuit in Missouri
Jul 13, 2016 | News Inferno
By Mara Lepmanis
In a consolidated litigation presently underway in Missouri, hundreds of talcum powder ovarian cancer lawsuits continue to move forward. Based on an Order issued on June 20 in the Missouri Circuit Court for St. Louis City, a trial scheduled to begin on February 21, will instead begin two weeks earlier, on February 6. The case concerns six plaintiffs who allege that their repeated, regular use of Johnson & Johnson’s (J&J) talc-based powders contributed to the development of ovarian cancer, reports Business News.
Plaintiffs claim that the use of J&J’s Baby Powder and other talcum products for feminine hygiene resulted in ovarian cancer. Decisions in the upcoming trial will provide some insight into how juries will decide other talcum powder lawsuits. More than 1,200 talcum powder ovarian cancer lawsuits are now pending around the country, Business News reports.
As early as the 1970s, plaintiffs allege that studies have indicated that the repeated and regular use of talc-based powders for feminine hygiene purposes increased the risk of ovarian cancer in women. Further allegations include that J&J has been aware of this connection for years, but profits came before consumer safety with the withholding of information and warnings from the public, according to Business News.
A jury in April, in St. Louis Missouri, awarded $55 million in compensatory and punitive damages to an ovarian cancer victim who used J&J’s talc-based powders for close to 40 years as part of her feminine hygiene regimen. In February, a jury ordered J&J to pay $72 million to the family of a woman who died as a result of ovarian cancer. As stated in the lawsuit, the deceased had used Baby Powder and Shower-to-Shower as part of her daily routine for over 30 years,Business News reports.
http://www.newsinferno.com/february-2017-date-set-for-talcum-powder-lawsuit-in-missouri/
-
$55 Million Verdict Second Against Johnson & Johnson in Talc Ovarian Cancer Lawsuit
Jul 13, 2016 | The Legal Examiner
By James Humann
In landmark verdicts this year two juries have found Johnson & Johnson liable for knowingly failing to warn customers that the company’s talcum powder products (including Shower-to-Shower and Johnson’s Baby Powder) have been linked to ovarian cancer in women.
First, in February 2016, a $72 million verdict was awarded to the family of a woman who died of the disease and, then again in May, a jury found against J&J and ordered the company to pay $55 million to Gloria Ristesund who was diagnosed with cancer in 2011 after using J&J’s talc-based feminine hygiene products for almost 40 years.
Things could get worse for the world’s largest maker of health-care products founded by Robert Wood Johnson in 1887. J&J is currently accused in more than 1,200 lawsuits of ignoring studies linking its popular talcum powder products to ovarian cancer. In the complaints, women contend the company knew of the risk yet failed to warn customers of the potential side effects.
After the Ristesund verdict, the jury forewoman stated, “We felt like [J&J] knew for decades that they should have put a warning on this product.”
The studies at issue suggest that the iconic Johnson’s Baby Powder may increase a woman’s risk of ovarian cancer if she uses it regularly in the genital area. Internal J&J documents used at trial showed the company was aware of health concerns since the mid-1970s. Despite this possible link, J&J has not placed warnings about this risk on their products. In fact, a 1992 corporate document suggested targeting women who were high users of talcum powder to boost sales.
In a few cases, the cancer was studied using an electron microscope and was found to have talc in the tissue thus supporting the claim that the cancer was caused by the body powder. Notably, talc was found in Ms. Ristesund’s ovarian tissue after her hysterectomy.
If a woman is diagnosed with ovarian cancer, she should consider the duration of talc powder use and whether there was regular contact of the product to her genital area. Talcum powder may have been the cause of the cancer.
If you or a loved one has been diagnosed with ovarian cancer after using talcum or baby powder contact the lawyers at Paglialunga and Harris.
http://sandiego.legalexaminer.com/uncategorized/55-million-verdict-second-against-johnson-johnson-in-talc-ovarian-cancer-lawsuit/
-
Jul 13, 2016 | Harris Martin Publishing
Imerys Talc America Inc. has filed a motion to dismiss a New Mexico talcum powder lawsuit on a number of grounds, including that the court does not have personal jurisdiction over the matter and that the plaintiffs’ civil conspiracy and fraud claims have not been pled with sufficient particularity.
In the July 1 motion filed in the U.S. District Court for the District of New Mexico, the defendant further maintained that since it is not a resident of New Mexico and the products at issue were purchased and used outside of the state, the venue is improper ...
Subscription required, for full text: http://harrismartin.com/article/21080/imerys-talc-moves-to-dismiss-talcum-powder-suit-on-jurisdiction-venue-and-failure-to-state-a-claim-grounds/
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
US Coverage
Add recipients
Suggested